AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31356475
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution alone
Trial: 24986373
Drug: Non-matched saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-matched saline infusion (sham-controlled group)
Trial: 20516538
Drug: Hydrocortisone acetate
RxNorm normalized name: Hydrocortisone Acetate
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone acetate (1.5 ml) and hyaluronidase (1500 IU) at weekly interval for 22 weeks
Trial: 20516538
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (10 mg/ml) and hyaluronidase (1500 IU) at 15 days interval for 22 weeks
Trial: 14685950
Drug: Insight: A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insight: A cognitive enhancement program for women (short-term cognitive group therapy)
Trial: 10232737
Drug: T cell
RxNorm normalized name: CD4CAR T cells
DrugBank: Anti-CD4 CAR T-cell therapy (DB17281)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T cell add-back therapy (up to 3 doses based on risk factors for GVHD)
Trial: 22502623
Drug: CAM intervention
RxNorm normalized name: phendimetrazine tartrate Oral Tablet [Cam-Metrazine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAM intervention (acupuncture, neural therapy with 1% procaine injection, cupping and bleeding, TCM herbs)
Trial: 22502623
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (wait-list, delayed treatment)
Trial: 18720710
Drug: Trimetazidin (TMZ)
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidin (TMZ) 35 mg
Trial: 15802415
Drug: Dexamethasone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (10 mg-10 mg-5 mg-5 mg intravenously every 12 hours)
Trial: 11787475
Drug: Moxonidine (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxonidine (0.4 mg)
Trial: 1989736
Drug: Epidural butorphanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural butorphanol 1 mg
Trial: 1989736
Drug: Epidural butorphanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural butorphanol 4 mg
Trial: 24733807
Drug: Piperacillin/tazobactam with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin/tazobactam with tigecycline (4.5 g IV every 8 hours + 50 mg IV every 12 hours; loading dose 100 mg)
Trial: 24733807
Drug: Piperacillin/tazobactam monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin/tazobactam monotherapy
Trial: 22036036
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 3000 mg in divided doses
Trial: 22036036
Drug: Ketamine (0.23
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.23 mg/kg bolus, followed by 0.58 mg/kg for 30 min, then 0.29 mg/kg for 40 min)
Trial: 19769634
Drug: Oral Sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Sodium Phosphosoda (OSPS)
Trial: 19769634
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of PEG and OSPS (PEG+OSPS)
Trial: 16321186
Drug: Alfacalcidol 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfacalcidol 1.0 microg/d plus calcium carbonate 750 mg Tid
Trial: 16321186
Drug: Alfacalcidol 0.5
RxNorm normalized name: alfacalcidol 0.5 MCG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfacalcidol 0.5 microg/d plus calcium carbonate 750 mg Tid
Trial: 16321186
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 750 mg Tid
Trial: 11895272
Drug: Healthy School
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy School and Drugs project (intervention)
Trial: 7615230
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg orally once daily for 7 days (n=8)
Trial: 2613380
Drug: Metoprolol (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (50-100 mg twice a day)
Trial: 2613380
Drug: Verapamil (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (40-80 mg three times a day)
Trial: 2613380
Drug: Digoxin (0.25-0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (0.25-0.5 mg daily)
Trial: 28077460
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of glyburide and metformin
Trial: 28077460
Drug: Glyburide and
RxNorm normalized name: Glyburide and metformin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide and Metformin
Trial: 25541376
Drug: Implantable pulmonary
RxNorm normalized name: Lobaria pulmonaria extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable pulmonary artery pressure monitoring device (treatment group)
Trial: 25541376
Drug: Implantable pulmonary
RxNorm normalized name: Lobaria pulmonaria extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable pulmonary artery pressure monitoring device (treatment group) in COPD subgroup
Trial: 19050164
Drug: Letrozole 2.5
RxNorm normalized name: letrozole 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole 2.5 mg daily for 28 days
Trial: 11343480
Drug: Medical antireflux
RxNorm normalized name: VALVE,ANTIREFLUX UROCARE #6001
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical antireflux therapy
Trial: 11343480
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (fundoplication)
Trial: 9702845
Drug: Eptastigmine 8
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Eptastigmine 8 mg
Trial: 7608318
Drug: Eptastigmine 20
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Eptastigmine 20 mg
Trial: 9702845
Drug: Eptastigmine 32
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Eptastigmine 32 mg
Trial: 9702845
Drug: Eptastigmine 40
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Eptastigmine 40 mg
Trial: 2685654
Drug: Sinemet CR
RxNorm normalized name: Sinemet CR
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Sinemet CR 50/200 mg
Trial: 2685654
Drug: Conventional carbidopa/levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional carbidopa/levodopa 25/250 mg
Trial: 790125
Drug: Raubasine (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raubasine (90 mg daily for 1-2 weeks)
Trial: 27801990
Drug: Eculizumab (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eculizumab (administered for 4 weeks alongside standard IVIg treatment)
Trial: 25133710
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein diet (1.8 g of protein·kg bw(‐1)·day(‐1))
Trial: 25133710
Drug: Normal protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal protein diet (0.85 g of protein·kg bw(‐1)·day(‐1))
Trial: 19350183
Drug: 308-nm excimer
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 308-nm excimer laser treatment, lesions treated twice weekly for 13 weeks, starting with 50 to 100 mJ/cm2 and increasing by 50 mJ/cm2 until erythema appeared, for a maximum of 25 sessions or until 100% repigmentation.
Trial: 12004315
Drug: Untreated control
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Untreated control patches
Trial: 17032095
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) combined with medication tapering
Trial: 17032095
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (nonspecific therapy)
Trial: 14645937
Drug: Behavioural cessation
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Behavioural cessation programme (four session treatment administered individually by a health educator, plus monthly brief phone calls until one year follow up)
Trial: 10386471
Drug: Goserelin 3.6
RxNorm normalized name: goserelin 3.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin 3.6 mg s.c. monthly + Flutamide 250 mg t.i.d. + Placebo daily
Trial: 10386471
Drug: Goserelin 3.6
RxNorm normalized name: goserelin 3.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin 3.6 mg s.c. monthly + Finasteride 10 mg (2 x 5 mg daily) + Placebo t.i.d.
Trial: 10386471
Drug: Finasteride 10
RxNorm normalized name: finasteride 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 10 mg (2 x 5 mg daily) + Flutamide 250 mg t.i.d.
Trial: 8697708
Drug: Normal daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal daily activities
Trial: 31839082
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine 7.5 mg plus fentanyl 20 μg (Group F)
Trial: 31839082
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine 10 mg (Group B)
Trial: 27849380
Drug: saxagliptin 5
RxNorm normalized name: sAXagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saxagliptin 5 mg/day plus dapagliflozin 10 mg/day
Trial: 27849380
Drug: saxagliptin 5
RxNorm normalized name: sAXagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saxagliptin 5 mg/day plus placebo
Trial: 27849380
Drug: dapagliflozin 10
RxNorm normalized name: dapagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dapagliflozin 10 mg/day plus placebo
Trial: 26343594
Drug: Risperidone +
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone + Dextromethorphan (60 mg/day)
Trial: 25099079
Drug: Erythropoietin (40,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (40,000 IU, 8 weekly infusions)
Trial: 18278305
Drug: Chloral hydrate
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloral hydrate 75 mg/kg
Trial: 18278305
Drug: Chloral hydrate
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloral hydrate 50 mg/kg plus hydroxyzine 2.0 mg/kg
Trial: 12177096
Drug: Low-dose suramin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose suramin (3.192 g/m²)
Trial: 12177096
Drug: Intermediate-dose suramin
RxNorm normalized name: suramin
DrugBank: Suramin (DB04786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate-dose suramin (5.320 g/m²)
Trial: 12177096
Drug: High-dose suramin
RxNorm normalized name: suramin
DrugBank: Suramin (DB04786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose suramin (7.661 g/m²)
Trial: 10094358
Drug: Continuous heparin
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous heparin drip
Trial: 3174726
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMW heparin) - 15,000 Anti X-activated Factor Units, daily subcutaneous injection for 7 days after operation
Trial: 3174726
Drug: Calcium heparin
RxNorm normalized name: HEPARIN CALCIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium heparin - 5,000 International Units, 2 daily subcutaneous injections for 7 days after operation
Trial: 18928413
Drug: Ziprasidone 80
RxNorm normalized name: ziprasidone 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone 80 or 160 mg/d (fixed dose) during Period 1
Trial: 18928413
Drug: Ziprasidone flexible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone flexible doses (20-160 mg/d) during Period 2
Trial: 21775917
Drug: Ringer's lactate
RxNorm normalized name: Ringer's lactate/gel dressing 2.2" TOPICAL KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer's lactate (RL) solution without colloid
Trial: 9868725
Drug: Antianxiety drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antianxiety drug (diazepam) with vitamin B complex
Trial: 7979299
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of oral diethyldithiocarbamate (DTC) per m2 weekly for 12 weeks
Trial: 3187472
Drug: Midazolam (5‐7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (5‐7.5 mg i.m., weight related)
Trial: 3764397
Drug: Hydrocodonum (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocodonum (15 mg i.m.)
Trial: 26549958
Drug: Naikan therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naikan therapy
Trial: 11667990
Drug: Ringer‐Lactate solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer‐Lactate solution
Trial: 8209072
Drug: Salbutamol via
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol via metered dose inhaler (MDI)
Trial: 26303741
Drug: Medicine control
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicine control
Trial: 21214610
Drug: TZP-101 (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TZP-101 (80 μg/kg)
Trial: 6356177
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg haloperidol tablets (average 4.0 tablets, 20.0 mg/day)
Trial: 6356177
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg haloperidol tablets (average 3.9 tablets, 58.0 mg/day)
Trial: 6356177
Drug: Higher oral
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher oral haloperidol doses
Trial: 28183347
Drug: Prehospital administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prehospital administration of thawed plasma
Trial: 22024668
Drug: Nebivolol 5
RxNorm normalized name: nebivolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol 5 mg/day (force-titrated to 10 mg/day after 1 week) in the morning
Trial: 22024668
Drug: Nebivolol 5
RxNorm normalized name: nebivolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol 5 mg/day (force-titrated to 10 mg/day after 1 week) in the evening
Trial: 19503772
Drug: Thermal laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thermal laser treatment
Trial: 19503772
Drug: Intravitreal injections
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injections of steroids
Trial: 19503772
Drug: Pharmaceuticals containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceuticals containing antibodies against vascular endothelial growth factor (VEGF)
Trial: 17244293
Drug: Cash and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cash and Counseling (treatment group) among elderly in Florida
Trial: 11928802
Drug: Breast conservation
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast conservation therapy as a primary therapeutic procedure
Trial: 7726705
Drug: Didanosine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine (500 mg/d)
Trial: 7726705
Drug: Didanosine (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine (750 mg/d)
Trial: 7726705
Drug: Zidovudine, Didanosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine, Didanosine (500 mg/d), Didanosine (750 mg/d)
Trial: 2304988
Drug: Silicone-gel implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silicone-gel implants
Trial: 2304988
Drug: Saline-filled implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline-filled implants
Trial: 6798924
Drug: Rosoxacin 100
RxNorm normalized name: rosoxacin
DrugBank: Rosoxacin (DB00817)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosoxacin 100 mg
Trial: 6798924
Drug: Rosoxacin 200
RxNorm normalized name: rosoxacin
DrugBank: Rosoxacin (DB00817)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosoxacin 200 mg, 300 mg, or 400 mg
Trial: 25004196
Drug: Yoga (1-hour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga (1-hour class weekly for 10 weeks)
Trial: 25004196
Drug: Control (supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (supportive women's health education, 1-hour class weekly for 10 weeks)
Trial: 21733292
Drug: Drug cues
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug cues in abstaining smokers
Trial: 20691131
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus PRSF-L477 (1 × 10¹¹ cfu daily for 3 weeks)
Trial: 10944134
Drug: Standard-dose neuraxis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose neuraxis irradiation (36 Gy in 20 fractions)
Trial: 10944134
Drug: Reduced-dose neuraxis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced-dose neuraxis irradiation (23.4 Gy in 13 fractions)
Trial: 1408298
Drug: Facet joint
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Facet joint injection
Trial: 18783503
Drug: Gabapentin (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (900 mg/day)
Trial: 3874009
Drug: 325 mg
RxNorm normalized name: lysine 325 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 325 mg tid aspirin (ASA) plus 75 mg tid dipyridamole (DP)
Trial: 3874009
Drug: 325 mg
RxNorm normalized name: lysine 325 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 325 mg tid aspirin (ASA)
Trial: 3874009
Drug: Platelet-inhibiting therapy
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-inhibiting therapy (ASA + DP)
Trial: 27902493
Drug: Intravenous amisulpride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amisulpride (5 mg)
Trial: 23715188
Drug: Amisped® (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisped® (5 mg montelukast chewable tablets)
Trial: 23715188
Drug: Singulair® (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Singulair® (5 mg montelukast chewable tablets)
Trial: 20131276
Drug: Golimumab 4
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Golimumab 4 mg/kg plus MTX
Trial: 17267204
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate plus etoposide and ifosfamide
Trial: 17267204
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate plus doxorubicin
Trial: 12377864
Drug: Topical 4%
RxNorm normalized name: menthol topical 4% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 4% amethocaine gel applied for 30 min prior to the radial arterial puncture
Trial: 12377864
Drug: Topical 4%
RxNorm normalized name: menthol topical 4% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 4% amethocaine gel
Trial: 4067888
Drug: Speech therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Speech therapy for 24 weeks starting at 10 weeks post-stroke
Trial: 28479412
Drug: Family-focused grief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-focused grief therapy (not specified dosage or duration)
Trial: 3472139
Drug: Oral scopolamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral scopolamine hydrobromide solution (ScHBr), 0.02 mg/kg total body weight, rinsed in the mouth for 5 minutes before swallowing
Trial: 3472139
Drug: Oral scopolamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral scopolamine hydrobromide solution (ScHBr) during clinical dental examination procedures
Trial: 3472139
Drug: Oral scopolamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral scopolamine hydrobromide solution (ScHBr)
Trial: 28718320
Drug: Prednisolone 37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 37.5 mg
Trial: 24002499
Drug: Antiviral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiviral treatment (nucleotide/nucleoside analogs: Lamivudine, adefovir dipivoxil, or entecavir)
Trial: 24002499
Drug: Antiviral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiviral treatment
Trial: 30983087
Drug: Prasugrel (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel (20 mg loading/3.75 mg maintenance)
Trial: 30983087
Drug: Clopidogrel (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300 mg loading/75 mg maintenance)
Trial: 25740805
Drug: Topical 5%
RxNorm normalized name: urea topical 5% topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 5% natamycin